Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-01-17

Clinical Trial Update: An Observational Study on Sarilumab-exposed Pregnancies

View source ↗

Summary

This entry documents the completion of an observational study evaluating pregnancy outcomes after exposure to sarilumab in women with rheumatoid arthritis, to a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Kevzara (sarilumab) (sarilumab)

Snippet

Sponsor: Sanofi | Conditions: Rheumatoid Arthritis -Exposure During Pregnancy | Status: COMPLETED